Introduction
Alcohol abuse during pregnancy can cause neurodevelopmental disorder in the fetus, or partial syndromes primarily affecting the central nervous system (CNS). Fetal alcohol syndrome has been characterized by distinctive, multifaceted clinical pictures (for review see Mattson and Riley, 2000; Streissguth and Martin, 1983) . Clinical and experimental evidence shows that alcohol exposure causes various disruptions in the proliferation and migration of neuronal and glial cells during development (Clarren et al., 1978; Miller, 1992) . It also impedes growth of the CNS in rats (Barron et al., 1988; Bauer-Moffett and Altman, 1975, 1977; Bonthius and West, 1990; Kornguth et al., 1979; Samson and Diaz, 1981; Sulik et al., 1981) and mice (Sari, 2009; Sari et al., 2009; Sari and Gozes, 2006; Sari and Zhou, 2004) . A recent study demonstrated alteration of the amniotic fluid proteome of alcohol-treated prenatally fetuses compared to control groups (Datta et al., 2008) .
The neurotoxic effects of ethanol may also cause disruptions in the development of neurotransmitter systems, such as the serotonin, dopamine, gamma-aminobutyric acid (GABA), glutamate and norepinephrine systems at prenatal or postnatal stages in rodents and non-human primates (Druse et al., 1991; Maier et al., 1996; Miller, 2006; Sari and Gozes, 2006; Sari et al., 2001; Sari and Zhou, 2004; Tajuddin and Druse, 1999; Zhou et al., 2002) . Serotonin is one of the first neurotransmitter systems to develop during ontogeny; it forms before the genesis of most other transmitter neurons. It has also been proposed that serotonin is a signaling chemical for neuronal development (for a review see Lauder, 1990) , and that during development serotonin acts to signal maturation of the CNS (Lauder, 1993; Whitaker-Azmitia We previously demonstrated that prenatal alcohol exposure results in brain defects at different embryonic stages. This study is aimed at characterizing the influence of prenatal alcohol exposure on the levels of several neurotransmitters at early embryonic stage 13 (E13). Pregnant C57BL/6 mice were exposed to either a 25% ethanol derived calorie diet (ALC) or pair-fed (PF) liquid diet from E7 to E13. At E13, fetal brains were collected from dams of the ALC and PF groups. Liquid chromatography/tandem mass spectrometry (LC-MS) was then used to evaluate neurotransmitter levels. This approach involved the use of an LC column in conjunction with multiple-reaction monitoring mass spectrometry. Quantitative analyses of catecholamines, idolamine, and amino acid neurotransmitters revealed significant reductions in the levels of dopamine (p = 0.004), norepinephrine (p = 0.0009), epinephrine (p = 0.0002), serotonin (p = 0.004), and GABA (p = 0.002) in the ALC group compared to the PF group. However, there was no significant change in the levels of glutamate in E13 fetal brains. These findings demonstrate that prenatal alcohol exposure reduces the concentrations of some catecholamines, idolamine, and amino acid neurotransmitters in E13 fetal brains. This study suggests that alterations of selective neurotransmitters may be the cause of abnormalities in brain function and behavior found in fetal alcohol spectrum disorders.
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